BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20233087)

  • 1. Synthesis, characterization, cytotoxicity, and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands.
    Utku S; Gumus F; Tezcan S; Serin MS; Ozkul A
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):502-8. PubMed ID: 20233087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands.
    Gümüş F; Eren G; Açik L; Celebi A; Oztürk F; Yilmaz S; Sagkan RI; Gür S; Ozkul A; Elmali A; Elerman Y
    J Med Chem; 2009 Mar; 52(5):1345-57. PubMed ID: 19220055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
    Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
    Vrzal R; Starha P; Dvorák Z; Trávnícek Z
    J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
    Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
    Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C
    Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and biological activity of Pt(II) and Pt(IV) complexes with 5-methyl-5(4-pyridyl)-2,4-imidazolidenedione.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ferdinandov D; Konstantinov S; Ivanov D
    Eur J Med Chem; 2008 May; 43(5):958-65. PubMed ID: 17707952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
    Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
    J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: trans-PtL(NH3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-alpha)pyridine.
    Huq F; Yu JQ; Daghriri H; Beale P
    J Inorg Biochem; 2004 Aug; 98(8):1261-70. PubMed ID: 15271501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, DNA interaction, and cytotoxicity of novel Pd(II) and Pt(II) complexes.
    Gao E; Liu F; Zhu M; Wang L; Huang Y; Liu H; Ma S; Shi Q; Wang N
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):557-64. PubMed ID: 20038273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of palladium(II) and platinum(II) complexes with Schiff bases derivatives of 2-pyridincarboxyaldehyde. Study of their interaction with DNA.
    García-Friaza G; Fernández-Botello A; Pérez JM; Prieto MJ; Moreno V
    J Inorg Biochem; 2006 Aug; 100(8):1368-77. PubMed ID: 16712937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
    Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
    Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of interaction of dichloro[eta2-dimethyl-(2-methylidene-cyclohexylmethyl)-amino]platinum(II) with DNA: effects on secondary and tertiary structures of DNA - cytotoxic assays on human cancer cell lines Capan 1 and A431.
    Gay M; Montaña AM; Moreno V; Prieto MJ; Llorens R; Ferrer L
    J Inorg Biochem; 2005 Dec; 99(12):2387-94. PubMed ID: 16256201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
    Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
    Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.